Paratek Completes Submission of New Drug Applications to U.S. Food and Drug Administration for Oral and Intravenous Omadacycline for Pneumonia and Skin Infections

World News: . []

BOSTON Feb 05 2018 GLOBE NEWSWIRE -- Paratek Pharmaceuticals Inc NasdaqPRTK announced today that on February 2 2018 it completed the submission of two New Drug Applications NDAs to the US Food and Drug Administration FDA for the Company...

More news and information about Paratek Pharmaceuticals

Published By:

Globe Newswire: 12:30 GMT Monday 5th February 2018

Published: .

Search for other references to "paratek" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us